Does a 2.9 cm inferior mesenteric vein aneurysm in a 54‑year‑old woman qualify as an unusual thrombosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

A 2.9 cm Inferior Mesenteric Vein Aneurysm Does NOT Qualify as an Unusual Thrombosis

An inferior mesenteric vein (IMV) aneurysm is a venous structural abnormality, not a thrombotic event, and therefore does not meet criteria for "unusual thrombosis" in the context of thrombophilia evaluation or antiphospholipid syndrome workup.

Understanding the Distinction

The question conflates two separate vascular pathologies:

  • Venous aneurysm: A focal dilation of a vein (in this case, the IMV measuring 2.9 cm)
  • Venous thrombosis: Blood clot formation within a vein

While IMV thrombosis can occur within an aneurysm 1, 2, the aneurysm itself is a structural vascular abnormality, not a thrombotic event. The term "unusual thrombosis" in clinical practice refers to venous thromboembolism (VTE) occurring in atypical anatomic locations—such as splanchnic veins, cerebral sinuses, or hepatic veins—which may warrant investigation for underlying thrombophilia 3.

When IMV Pathology Becomes Relevant to Thrombosis Assessment

If thrombosis develops within the IMV aneurysm, then the thrombotic event itself would qualify as an unusual site thrombosis, specifically splanchnic vein thrombosis (SPVT). In this scenario:

  • The thrombosis location (mesenteric venous system) is unusual and warrants thrombophilia workup 4, 1
  • Evaluation should include testing for antiphospholipid syndrome, JAK2 mutation, paroxysmal nocturnal hemoglobinuria (PNH), and inherited thrombophilias 4
  • The presence of the underlying aneurysm represents a local anatomic risk factor but doesn't negate the need for systemic thrombophilia evaluation 1

Clinical Management of the 2.9 cm IMV Aneurysm

This 2.9 cm IMV aneurysm warrants interventional treatment based on size criteria 5:

  • Splanchnic venous aneurysms >2-2.5 cm require intervention due to rupture risk 5
  • At 2.9 cm, this exceeds the conservative management threshold
  • Endovascular treatment should be proposed over open surgery when technically feasible 5

Treatment Algorithm:

  1. Confirm diagnosis with contrast-enhanced CT showing venous phase imaging 5
  2. Assess for associated arteriovenous fistula (can cause venous aneurysm formation) 6
  3. Evaluate for underlying causes:
    • Portal hypertension 5
    • Prior trauma or surgery 6
    • Connective tissue disorders
  4. Proceed with intervention given size >2.5 cm:
    • Endovascular options: embolization, covered stent 6
    • Surgical ligation if endovascular not feasible 7

Common Pitfall to Avoid

Do not dismiss this as simply an incidental finding requiring only surveillance. At 2.9 cm, this aneurysm exceeds conservative management thresholds and carries significant rupture risk. While smaller splanchnic venous aneurysms (<2 cm) can be monitored with serial imaging at 6-12 months initially 5, this patient's aneurysm size mandates active intervention.

The 54-year-old woman's demographic (premenopausal age) doesn't confer the same high-risk status as pregnancy or liver transplant candidacy, but the size criterion alone is sufficient indication for treatment 5.

References

Guideline

venous thromboembolic disease.

Journal of the National Comprehensive Cancer Network : JNCCN, 2011

Research

Giant Inferior Mesenteric Vein Aneurysm Secondary to Iatrogenic Inferior Mesenteric Arteriovenous Fistula.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2024

Research

Management of an enormous inferior mesenteric vein aneurysm.

Journal of vascular surgery. Venous and lymphatic disorders, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.